SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?

The 10 Top-Rated Stocks by Wall Street Analysts in June 2021

The 10 Top-Rated Stocks by Wall Street Analysts in May 2021

Analyst ratings are an imperfect science. However, they do reflect the sentiment of individuals who have significant knowledge of a company’s operations. Ratings are done on a scale from 1.00 to 4.00. A score of 4.00 is equivalent to a “strong buy” rating. By contrast a score of 1.00 is equivalent to a “sell” rating. For a company to be included on MarketBeat’s list they must have received at least five ratings within the last 12 months. Here are the top 10 top-rated stocks by Wall Street analysts in June 2021:

  1. AltaGas (OTCMKTS:ATGFF) – Traditional energy stocks have been making a comeback in 2021. So it shouldn’t be that much of a surprise that AltaGas tops this list. ATGFF stock is up over 44% in 2021 and has a consensus score of 3.10 among 10 analysts. The company’s stock is projected to have an upside of over 26% in the next 12 months.
  2. Teleflex (NYSE:TFX) – Another market sector that is expected to perform well in 2021 is the medical equipment sector. Elective surgeries were delayed in 2020 due to the Covid-19 pandemic. However as hospitals and medical centers look to recoup that revenue in 2021, there is a big opportunity for Teleflex which manufactures specialty medical devices. The stock is flat for the year. However, 10 analysts give TFX stock a score of 3.10 with an upside of over 14%.
  3. Brigham Minerals (NYSE:MNRL) – Brigham Minerals is another highly rated stock in the energy sector. Specifically, Brigham Minerals focuses on acquiring oil and gas rights from landowners throughout the United States. MNRL stock is up 84% in 2021 and has a 3.10 rating among 10 analysts. A note of caution is in order as the consensus price target has the stock dropping by 21% over the next 12 months. However, the company reports earnings in August and that may change the outlook.
  4. Vodafone Group (NASDAQ:VOD) –Vodafone is a multinational telecommunications company headquartered in the United Kingdom. VOD stock is flat for the year as the economic reopening in Europe has not been as smooth as in the United States. Still at one point, the stock was up 20% for the year. And analysts give the stock a 3.10 rating suggesting that the stock is likely to grow strongly in the second half of 2021.
  5. CymaBay Therapeutics (NASDAQ:CBAY) – As the race for a Covid-19 vaccine comes to a conclusion, investors are looking at other biotech companies. And at this time, they like what they are seeing from CymaBay Therapeutics. The company’s stock is up approximately 28% in the 12 months ending on June 28. However, CBAY stock is down about 21% in 2021. Still, the company has a consensus rating among 10 analysts of 3.09. And the company’s stock price is projected to grow by 138% for the remainder of 2021.
  6. Health Catalyst (NASDAQ:HCAT) – Health Catalyst positions investors in the healthcare and data analytics sectors. HCAT stock has a 3.09 rating among 11 analysts, but the consensus price target shows a 14% downside risk in the next 12 months. However, revenue has been trending in a positive direction and the company is getting closer to becoming profitable. Analysts will be looking for this trend to continue when the company reports earnings in August.
  7. Tourmaline Oil (OTCMKTS:TRMLF) – Returning to oil stocks, we have Tourmaline Oil which has a consensus rating of 3.09 among 11 analysts. With the price of crude oil expected to continue to rise in 2021, it’s no surprise that TRMLF stock is projected to have upside price growth of over 47%. That would continue its strong upward movement in 2021 in which the stock is up over 96%.
  8. Gaming and Leisure Properties (NASDAQ:GLPI) – The gaming industry is another area of strong growth for the market in 2021. Gaming and Leisure Properties is a real estate investment trust (REIT) that has an innovative model in which they enter into triple-net lease agreements with gaming operators. The stock is up nearly 13% in 2021 and analysts give the stock a possible upside of over 8% in the next 12 months. The stock carries a 3.08 rating among 12 analysts.
  9. Rackspace Technology (NASDAQ:RXT) – Rackspace Technology is a global cloud services company. Like many stocks in the tech sector, RXT stock has been volatile this year. However, analysts give the stock a 3.08 rating with a possible upside of over 42% in the next 12 months, which would be more than double the growth of the stock in the past 12 months.
  10. S&P Global (NYSE:SPGI) – S&P Global provides ratings, benchmarks, analytics and data to global capital and commodity markets. SPGI stock is up over 23% in 2021 and over 28% in the last 12 months. The stock receives a 3.08 rating among the 12 analysts that provide coverage. While the consensus price target suggests little upside, recent analyst reports have come with boosted price targets.

7 Stocks to Buy to Outrun Rising Interest Rates

The latest Consumer Price Index (CPI) reading indicates that inflation may be peaking. But if you go to the grocery store or pay rent you're aware that prices aren't going down anytime soon. In fact, there's growing sentiment that inflation will be sticky.

What does that mean for interest rates? One part of the Federal Reserve's dual mandate is to keep inflation at or near its 2% target level. That means that it's reasonable to suggest that the Fed is not done with rate hikes.

Rising interest rates generally spell trouble for equity investors. Businesses, like consumers, are affected by higher interest rates. Not to be overly simplistic, but hiring borrowing costs means lower earnings. And that means a lower stock price.

However, some stocks manage rising interest rates better than others. In this special presentation, we look at seven stocks that are built to outperform when interest rates are rising. And what's even better, many of these stocks have business models that provide growth when the economy is firing on all cylinders.

View the Stocks Here .

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
CymaBay Therapeutics (CBAY)
2.4864 of 5 stars
$3.47+1.8%N/A-2.67Buy$11.00
Vodafone Group Public (VOD)
2.4553 of 5 stars
$11.40-2.5%7.72%N/AHold$134.33
Brigham Minerals (MNRL)
2.2119 of 5 stars
$27.99+2.3%2.29%13.59Moderate Buy$34.60
Teleflex (TFX)
2.6657 of 5 stars
$199.43-3.0%0.68%18.53Moderate Buy$322.70
Health Catalyst (HCAT)
2.802 of 5 stars
$10.17-4.0%N/A-3.48Moderate Buy$25.62
Tourmaline Oil (TRMLF)
0 of 5 stars
$56.26-0.3%N/AN/ABuy$89.69
Gaming and Leisure Properties (GLPI)
2.6606 of 5 stars
$46.46-1.9%6.07%20.93Moderate Buy$54.80
Rackspace Technology (RXT)
2.2282 of 5 stars
$4.45-4.1%N/A-4.78Hold$9.10
S&P Global (SPGI)
3.2685 of 5 stars
$316.17-1.7%1.08%23.56Moderate Buy$404.71
Compare These Stocks  Add These Stocks to My Watchlist 

Chris Markoch

About Chris Markoch

Contributing Author: Retirement, Individual Investing

Chris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.

Contact Chris Markoch via email at CTMarkoch@msn.com.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.